The PTEN Research Foundation is delighted to announce the launch of its newsletter. In September's issue, you can read our recent news, including details of a new clinical trial testing a potential treatment for PHTS.
Launch of Clinical Trial to Investigate the Efficacy on Neurocognition and Behaviour of Everolimus in Children and Adolescents with PTEN Mutations
28 June 2017
June 2017 Overview The Boston Children's Hospital, Cleveland Clinic and Stanford University Medical Center, as part of the Developmental Synaptopathies Consortium (DSC), have launched their first clinical trial to investigate a potential treatment for individuals with PTEN Hamartoma Tumour Syndrome (PHTS). PHTS is a rare genetic syndrome that results from mutations in the PTE ...
Presentations from “Cowden Syndrome and Other PTEN-Related Disorders: A Patient-Oriented Symposium”
15 June 2017
On June 10th, Dr Maria Whitehead, Director of Research for the PTEN Research Foundation, presented at the “Cowden Syndrome and Other PTEN-Related Disorders: A Patient-Oriented Symposium” at The Ohio State University Wexner Medical Centre. Please follow the link to view all of the presentations from the day which include: Partnering with Your New or Current Primary Care Phy ...
Ohio State University: Cowden Syndrome Symposium, June 10, 2017
12 May 2017
Cowden Syndrome and Other PTEN-Related Disorders: A Patient-Oriented Symposium June 2017 Join us for our annual educational conference focused on Cowden syndrome and other PTEN mutation-related disorders. This event is geared towards affected patients and their families but all are welcome to attend. The event will feature experts in the fields of Genetics, Gastroenterology, ...